کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
6551260 | 1421966 | 2018 | 21 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
An alternative carrier solvent for fingermark enhancement reagents
ترجمه فارسی عنوان
یک حلال جایگزین حامل برای واکنش های تقویت انگشت
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
مهندسی و علوم پایه
شیمی
شیمی آنالیزی یا شیمی تجزیه
چکیده انگلیسی
Solstice® Performance Fluid (PF), trans-1-chloro-3,3,3-trifluoropropene, is presented as an alternative to HFE7100, methoxy-nonafluorobutane, as a carrier solvent in a number of chemical formulations used for the visualisation of latent fingermarks. The supply of HFE7100 may be at risk due to a recent European Union regulation to control global warming. Laboratory trials using split depletions and a pseudo-operational trial of 1000 porous samples have shown that Solstice® PF is a viable alternative to HFE7100 for the chemical formulations of ninhydrin and 1,2-indanedione. Other preliminary trials have also indicated that Solstice® PF can be used as a carrier solvent for the zinc toning of marks found using ninhydrin as well as the α-naphtholflavone fixative solution for iodine developed marks. Results from the pseudo-operational trial demonstrate that the number of marks detected by ninhydrin and 1,2-indanedione formulations for each carrier solvent is comparable. When compared to HFE7100, advantages of Solstice® PF include a very low global warming potential and atmospheric lifetime in addition to a higher wetting index and lower costs. This study also provides a validation study that supports the potential replacement of DFO with 1,2-indanedione.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Forensic Science International - Volume 284, March 2018, Pages 53-64
Journal: Forensic Science International - Volume 284, March 2018, Pages 53-64
نویسندگان
Izabela Olszowska, Paul Deacon, Maurice Lindsay, Adam LeÅniewski, Joanna NiedzióÅka-Jönsson, Kevin Farrugia,